Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
2011

How Hyaluronic Acid-Chitosan Nanoparticles Enter Eye Cells

publication Evidence: moderate

Author Information

Author(s): Laura Contreras-Ruiz, María de la Fuente, Jenny E. Párraga, Antonio López-García, Itziar Fernández, Begoña Seijo, Alejandro Sánchez, Margarita Calonge, Yolanda Diebold

Primary Institution: Ocular Surface Group-IOBA, University of Valladolid, Valladolid, Spain

Hypothesis

The study aims to determine the internalization pathway used by ocular surface cell lines to take up hyaluronic acid-chitosan oligomer-based nanoparticles.

Conclusion

Hyaluronic acid-chitosan nanoparticles are effectively internalized by ocular surface cells through an active transport mechanism without compromising cell viability.

Supporting Evidence

  • HA-CSO nanoparticles were internalized by corneal and conjunctival cells through an active transport mechanism.
  • The uptake was significantly reduced by blocking hyaluronan receptors.
  • Most of the nanoparticles were metabolized within 48 hours without affecting cell viability.

Takeaway

Scientists created tiny particles to help deliver medicine to the eye, and they found that these particles can get into eye cells safely and effectively.

Methodology

The study involved creating nanoparticles and exposing human epithelial cell lines to them, followed by fluorescence microscopy and fluorometry to assess uptake.

Limitations

The study does not explore all potential uptake mechanisms and focuses primarily on two cell lines.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication